Gene · 79679
NIH grants878
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 878
Download this page as JSON| Grant | Title | VTCN1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI132963 | Novel humanized mouse model developed from cord blood CD34 positive HSC and autologous iPS cell derived thymus | 1 | 2021 |
| R01CA202948 | Interplay between ER and TGF-b in carcinogenesis | 1 | 2021 |
| R01CA206483 | (PQ1) Lipid Metabolism, Inflammation, and T cell Dysfunction in HIV-associated Cancer | 1 | 2021 |
| R01CA206529 | Regulation of ER-beta Signaling in Carcinogenesis | 1 | 2021 |
| R01CA211016 | Immune Impact on Cancer Chemoresistance | 1 | 2021 |
| R01CA211052 | Optimizing biologically-based rational polytherapy in ALK+ lung cancer | 1 | 2021 |
| R01CA211794 | Role of p62/SQSTM1 in obesity-induced liver cancer | 1 | 2021 |
| R01CA212605 | Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect | 1 | 2021 |
| R01CA213293 | Protein Arginine Methylation in Chemotherapy Resistance | 1 | 2021 |
| R01CA214871 | The roles of TRIM24 in breast cancer | 1 | 2021 |
| R01CA216410 | Developing Nano Technology for HER2 Directed Therapy | 1 | 2021 |
| R01CA216846 | Renalase inhibition for treatment of unresectable melanoma | 1 | 2021 |
| R01CA217207 | The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling | 1 | 2021 |
| R01CA217510 | Naive T cells in Cancer Immune Evasion and Immunotherapy | 1 | 2021 |
| R01GM125871 | A Technique for Measuring Transcription Factor Activity | 1 | 2021 |
| R01HL135325 | CD27/CD70 mediated negative regulation of inflammatory T cell responses | 1 | 2021 |
| R01HL140470 | Complement driven innate and adaptive autoreactivity in lung transplantation | 1 | 2021 |
| R01NS097649 | Targeting Mechanisms of Acquired Temozolomide Resistance in Glioblastoma | 1 | 2021 |
| R01NS102669 | Tissue Factor as a Key Determinant of IDH1 Mutant versus IDH1 Wild-type Glioma Thrombosis and Malignancy | 1 | 2021 |
| R01NS105556 | Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/grants?page=17